Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Lenskart SolutionsNSE:LENSKART -0.69%12 Days Payable is 110.33 as of Jun. 2026, which is 5% below its 10-year median of 116.55. GuruFocus rates NSE:LENSKART with a GF Score™ of 12/100. The stock has 4 warning signs investors should review. Among 794 Medical Devices & Instruments companies, Lenskart Solutions ranks better than 75.94% on this metric.
The historical rank and industry rank for Lenskart Solutions's Days Payable or its related term are showing as below:
NSE:LENSKART'
s Days Payable Range Over the Past 10 Years
Min: 112.43 Med: 116.55 Max: 160.87
Current: 138.16
During the past 4 years, Lenskart Solutions's highest Days Payable was 160.87. The lowest was 112.43. And the median was 116.55.
NSE:LENSKART's Days Payable is ranked better than 75.94% of 794
companies
in the Medical Devices & Instruments industry
Industry Median: 68.505
vs NSE:LENSKART: 138.16
Lenskart Solutions's Days Payable
declined
from Mar. 2025 (122.94) to Jun. 2026 (110.33).
It may suggest that Lenskart Solutionsaccelerated paying its suppliers.
The historical data trend for Lenskart Solutions's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:LENSKART vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, Lenskart Solutions's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Lenskart Solutions Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Lenskart Solutions's Days Payable distribution charts can be found below:
* The bar in red indicates where Lenskart Solutions's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Lenskart Solutions's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Lenskart Solutions (NSE:LENSKART) has a Days Payable of 110.33 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Lenskart Solutions and its competitors. This is near median its historical median of 116.55. Over the past decade, Lenskart Solutions' Days Payable has ranged from 112.43 to 160.87. According to the industry distribution chart, Lenskart Solutions ranks #191 out of 794 companies in the Medical Devices & Instruments industry, placing it in the top 24.1%.
Is Lenskart Solutions' Days Payable too high?
Lenskart Solutions' current Days Payable of 110.33 is near median its 10-year median of 116.55. Over the past 10 years, this metric has ranged from a low of 112.43 to a high of 160.87. The Medical Devices & Instruments industry median Days Payable is 68.51. Lenskart Solutions' value of 110.33 is 61.1% above this industry median. Based on the distribution chart, Lenskart Solutions ranks #191 out of 794 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Lenskart Solutions has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Lenskart Solutions' Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Lenskart Solutions ranks #191 out of 794 companies for Days Payable. This places Lenskart Solutions in the top 24% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.51. Lenskart Solutions' value of 110.33 is 61.1% above this benchmark. Historically, Lenskart Solutions' own Days Payable has ranged from 112.43 to 160.87 over the past decade. While the company's 10-year median is 116.55 vs. the industry median of 68.51, Lenskart Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.51, based on 794 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Lenskart Solutions's current Days Payable of 110.33 is 61.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Lenskart Solutions and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Lenskart Solutions's current Days Payable is 110.33, which is near median its own 10-year median of 116.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Lenskart Solutions stock overvalued right now?
Lenskart Solutions (NSE:LENSKART) has a current Days Payable of 110.33. The current Days Payable is 110.33, which is near median its 10-year median of 116.55 and 61.1% above the Medical Devices & Instruments industry median of 68.51. Lenskart Solutions' overall GF Score™ is 12/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Lenskart Solutions (NSE:LENSKART), the current Days Payable is 110.33 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Lenskart Solutions Ltd is a technology-driven eyewear company, with a belief that clear vision is fundamental to personal development and well-being. It sells a range of eyewear products including prescription eyeglasses, sunglasses, and other products such as contact lenses and eyewear accessories.
12GF Score
Get the complete analysis for NSE:LENSKART
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:LENSKART has been successfully added to your 
